Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Shares withheld for taxes SVP, Products Business gave up 464 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,733 shares (to pay taxes)
  3. 4 Planned sale Director sold 7,844 shares at $6.30 ($49,417)
  4. 8-K Event Other events
  5. 144 Insider Sale of Securities
  6. 4 Open-market buy President and CEO bought 60,000 shares at $5.83 ($349,800)
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations · Regulation FD disclosure
  9. 8-K Event Shareholder vote results
  10. 4 Grant or award Director acquired 34,403 shares (grant or award)
  11. 4 Grant or award Director acquired 34,403 shares (grant or award)
  12. 4 Grant or award Director acquired 34,403 shares (grant or award)
  13. 4 Grant or award Director acquired 34,403 shares (grant or award)
  14. 4 Grant or award Director acquired 34,403 shares (grant or award)
  15. 4 Grant or award Director acquired 34,403 shares (grant or award)
  16. 4 Grant or award Chairman acquired 34,403 shares (grant or award)
  17. 4 Grant or award Director acquired 34,403 shares (grant or award)
  18. 4 Grant or award Director acquired 34,403 shares (grant or award)
  19. 4 Shares withheld for taxes SVP, Bioservices gave up 561 shares (to pay taxes)
  20. 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 480 shares (to pay taxes)

Page 7 of 87 · 1,733 filings